Many previous studies suggest that increased t-tau and decreased p-tau/t-tau ratio may be used as predictive or diagnostic ALS biomarkers [11,32,34,35,36,37], whereas the clinical significance of Abeta42 is more debated [38]. Here, MAPT is linked to amyotrophic lateral sclerosis.